Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMND-100 in Healthy Volunteers and Subjects With Alcohol Use Disorder
NCT05913752Phase 2Recruiting
- Sponsor
- Clearmind Medicine
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of 5-methoxy-2-aminoindane in alcohol use disorder (AUD), sponsored by Clearmind Medicine. Started Apr 2025; status: recruiting.
02
Drugs
5-methoxy-2-aminoindane
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05913752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05913752.